Reginster JY - Search Results

1

A scoping review of the public health impact of vitamin D-fortified dairy products for fracture prevention.

Hiligsmann M, Neuprez A, Buckinx F, Locquet M, Reginster JY. Hiligsmann M, et al. Among authors: reginster jy. Arch Osteoporos. 2017 Dec;12(1):57. doi: 10.1007/s11657-017-0352-1. Epub 2017 Jun 21. Arch Osteoporos. 2017. PMID: 28634891 Free PMC article. Review.

2

Developments in the pharmacotherapeutic management of osteoporosis.

Close P, Neuprez A, Reginster JY. Close P, et al. Among authors: reginster jy. Expert Opin Pharmacother. 2006 Aug;7(12):1603-15. doi: 10.1517/14656566.7.12.1603. Expert Opin Pharmacother. 2006. PMID: 16872263 Review.

3

Vitamin D inadequacy in Belgian postmenopausal osteoporotic women.

Neuprez A, Bruyère O, Collette J, Reginster JY. Neuprez A, et al. Among authors: reginster jy. BMC Public Health. 2007 Apr 26;7:64. doi: 10.1186/1471-2458-7-64. BMC Public Health. 2007. PMID: 17462085 Free PMC article.

4

Intermittent bisphosphonate therapy in postmenopausal osteoporosis: progress to date.

Reginster JY, Malaise O, Neuprez A, Jouret VE, Close P. Reginster JY, et al. Drugs Aging. 2007;24(5):351-9. doi: 10.2165/00002512-200724050-00001. Drugs Aging. 2007. PMID: 17503893 Free article. Review.

5

Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy.

Reginster JY, Collette J, Neuprez A, Zegels B, Deroisy R, Bruyere O. Reginster JY, et al. Bone. 2008 May;42(5):832-6. doi: 10.1016/j.bone.2008.01.021. Epub 2008 Feb 15. Bone. 2008. PMID: 18316258 Free article.

6

Low dietary calcium in European postmenopausal osteoporotic women.

Bruyere O, De Cock C, Mottet C, Neuprez A, Malaise O, Reginster JY. Bruyere O, et al. Among authors: reginster jy. Public Health Nutr. 2009 Jan;12(1):111-4. doi: 10.1017/S1368980008002024. Epub 2008 Apr 15. Public Health Nutr. 2009. PMID: 18410703 Free article.

7

Ibandronate in profile: drug characteristics and clinical efficacy.

Reginster JY, Neuprez A, Bruyère O. Reginster JY, et al. Expert Opin Drug Metab Toxicol. 2008 Jul;4(7):941-51. doi: 10.1517/17425255.4.7.941. Expert Opin Drug Metab Toxicol. 2008. PMID: 18624681 Review.

8

Lifetime absolute risk of hip and other osteoporotic fracture in Belgian women.

Hiligsmann M, Bruyère O, Ethgen O, Gathon HJ, Reginster JY. Hiligsmann M, et al. Among authors: reginster jy. Bone. 2008 Dec;43(6):991-4. doi: 10.1016/j.bone.2008.08.119. Epub 2008 Sep 10. Bone. 2008. PMID: 18817901

9

Bone-forming agents in the management of osteoporosis.

Neuprez A, Reginster JY. Neuprez A, et al. Among authors: reginster jy. Best Pract Res Clin Endocrinol Metab. 2008 Oct;22(5):869-83. doi: 10.1016/j.beem.2008.06.003. Best Pract Res Clin Endocrinol Metab. 2008. PMID: 19028361 Review.

10

Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.

Neuprez A, Hiligsmann M, Scholtissen S, Bruyere O, Reginster JY. Neuprez A, et al. Among authors: reginster jy. Adv Ther. 2008 Dec;25(12):1235-56. doi: 10.1007/s12325-008-0125-8. Adv Ther. 2008. PMID: 19066755 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

977 results

Search Page